Alkem Laboratories Q2FY27 Results: Revenue Up 13.8% YoY, PAT Down 11.7%
Alkem Laboratories Ltd · Financial Result · 12 Nov 2026, 7:25 pm
Alkem Laboratories Q2FY27 Results: Revenue Up 13.8% YoY, PAT Down 11.7% Alkem Laboratories reported consolidated Q2FY27 revenue from operations of ₹45,520 mn, rising 13.8% YoY (up 21.7% QoQ), supported by India sales growth of 9.5% YoY to ₹30,275 mn and international sales expansion of 22.3% YoY to ₹14,540 mn. EBITDA rose 11.3% YoY to ₹10,252 mn, with margins at 22.5% (down 50 bps YoY). Net profit attributable to owners declined 11.7% YoY to ₹6,753 mn due to a higher effective tax rate. The company completed its 55% stake acquisition in Occlutech on 16th Jul'26.
Original exchange filing (PDF)
More announcements from Alkem Laboratories Ltd
- Please find attached herewith Q2 H1FY2027 - Earnings Conference Call Transcript · 18 Nov 2026
- With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of the '' Q2 and H1FY27 Earnings Conference Call'' .... · 13 Nov 2026
- We wish to inform you that the Company has appointed Mr. Gopal Kothari as the CFO and KMP of the Company wef 2nd Dec, 2026. · 12 Nov 2026
- Pl find enclosed press release and analyst presentation on Q2 and H1FY27 earnings and business updates of the Company · 12 Nov 2026
- Alkem Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 12 Nov 2026
- Please find enclosed herewith the outcome of Board meeting dated 12th Nov, 2026. The meeting of the Board of Directors of the Company commenced at 11.30 am and concluded at 13.40. · 12 Nov 2026
- Please find attached herewith intimation of incorporation of subsidiary in the form of Joint Venture. · 09 Nov 2026
- With reference to your email regarding the captioned corporate announcement submitted by the Company on 03rd November, 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure .... · 05 Nov 2026
